Article info
Inflammatory bowel disease
Original article
Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response
- Correspondence to Professor Huey-Kang Sytwu, Professor of Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, 161, Section 6, Min-Chuan East Road, Neihu District, Taipei 114, Taiwan; sytwu{at}ndmctsgh.edu.tw
Citation
Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response
Publication history
- Received December 11, 2013
- Revised June 17, 2014
- Accepted June 18, 2014
- First published July 10, 2014.
Online issue publication
April 01, 2015
Article Versions
- Previous version (10 July 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions